Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome | Zendy

Frédéric Sacher | Zendy; Vincent Probst | Zendy; Yoshito Iesaka | Zendy; Peggy Jacon | Zendy; Julien Laborderie | Zendy; Frédérique Mizon-Gérard | Zendy; Philippe Mabo | Zendy; Sylvain Reuter | Zendy; D Lamaison | Zendy; Yoshihide Takahashi | Zendy; Mark O’Neill | Zendy; Stéphane Garrigue | Zendy; Bertrand Pierre | Zendy; Pierre Jaı̈s | Zendy; JeanLuc Pasquié | Zendy; Mélèze Hocini | Zendy; M Salvador-Mazenq | Zendy; Akihiko Nogami | Zendy; A Amiel | Zendy; Pascal Defaye | Zendy; Pierre Bordachar | Zendy; Serge Bovéda | Zendy; Philippe Maury | Zendy; Didier Klug | Zendy; Dominique Babuty | Zendy; Michel Haı̈ssaguerre | Zendy; Jacques Mansourati | Zendy; Jacques Clémenty | Zendy; Hervé Le Marec | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome

Author(s) -

Frédéric Sacher,

Vincent Probst,

Yoshito Iesaka,

Peggy Jacon,

Julien Laborderie,

Frédérique Mizon-Gérard,

Philippe Mabo,

Sylvain Reuter,

D Lamaison,

Yoshihide Takahashi,

Mark O’Neill,

Stéphane Garrigue,

Bertrand Pierre,

Pierre Jaı̈s,

JeanLuc Pasquié,

Mélèze Hocini,

M Salvador-Mazenq,

Akihiko Nogami,

A Amiel,

Pascal Defaye,

Pierre Bordachar,

Serge Bovéda,

Philippe Maury,

Didier Klug,

Dominique Babuty,

Michel Haı̈ssaguerre,

Jacques Mansourati,

Jacques Clémenty,

Hervé Le Marec

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.628537

Subject(s) - medicine , brugada syndrome , ventricular fibrillation , implantable cardioverter defibrillator , defibrillation threshold , cardiology , asymptomatic , ventricular tachycardia , sudden cardiac death , defibrillation , population , complication , environmental health

Brugada syndrome is an arrhythmogenic disease characterized by an increased risk of sudden cardiac death (SCD) by ventricular fibrillation. At present, an implantable cardioverter-defibrillator (ICD) is the recommended therapy in high-risk patients. This multicenter study reports the outcome of a large series of patients implanted with an ICD for Brugada syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research